Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.180
-0.280 (-6.28%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $414.56 million as of July 17, 2026. Its market cap has increased by 569.44% in one year.
Market Cap
414.56M
Enterprise Value
350.73M
1-Year Change
569.44%
Ranking
Category
Stock Price
$4.18
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $414.56M, a decrease of -48.61%. That is a compound annual growth rate of -10.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 414.56M | 73.49% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 459.13M |
| Artiva Biotherapeutics | 454.30M |
| Prothena Corporation | 452.33M |
| Benitec Biopharma | 445.92M |
| Cabaletta Bio | 435.36M |
| Evommune | 431.86M |
| Sutro Biopharma | 431.33M |
| Puma Biotechnology | 421.45M |